AVITA Medical, Inc. (RCEL)
12.72
+0.71
(+5.91%)
USD |
NASDAQ |
Oct 02, 16:00
12.66
-0.06
(-0.51%)
After-Hours: 20:00
AVITA Medical Net Income (Quarterly) : -7.663M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.663M |
| March 31, 2026 | -10.61M |
| December 31, 2025 | -11.62M |
| September 30, 2025 | -13.19M |
| June 30, 2025 | -9.92M |
| March 31, 2025 | -13.86M |
| December 31, 2024 | -11.59M |
| September 30, 2024 | -16.20M |
| June 30, 2024 | -15.39M |
| March 31, 2024 | -18.66M |
| December 31, 2023 | -7.065M |
| September 30, 2023 | -8.712M |
| Date | Value |
|---|---|
| June 30, 2023 | -10.38M |
| March 31, 2023 | -9.22M |
| December 31, 2022 | -5.353M |
| September 30, 2022 | -5.588M |
| June 30, 2022 | -6.261M |
| March 31, 2022 | -9.463M |
| June 30, 2021 | -4.718M |
| March 31, 2021 | -5.997M |
| December 31, 2020 | -5.641M |
| September 30, 2020 | -10.23M |
| June 30, 2020 | -12.91M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 229.91M |
| Iovance Biotherapeutics, Inc. | -47.32M |
| Amgen, Inc. | 2.375B |
| Editas Medicine, Inc. | -18.23M |
| Arcus Biosciences, Inc. | -91.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 21.70M |
| Total Expenses (Quarterly) | 29.36M |
| EPS Diluted (Quarterly) | -0.2492 |
| Enterprise Value | 430.73M |
| Gross Profit Margin (Quarterly) | 81.87% |
| Profit Margin (Quarterly) | -35.31% |
| Earnings Yield | -11.35% |
| Normalized Earnings Yield | -11.71 |